Vitamin B6: Beyond adequacy

Journal of Evidence-Based Complementary and Alternative Medicine

Volumn 16, Issue 2, 2011, Pages 29-39

  Bender, David A ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Autism; Cancer; Carpal tunnel syndrome; Dementia; Depression; Premenstrual syndrome; Pyridoxamine; Pyridoxine; Vitamin B6

Indexed keywords

EID: 79957957472     PISSN: 21565872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (120)

1. Bender DA. Vitamin B6 requirements and recommendations. Eur J Clin Nutr. 1989;43:289-309.
2. Institute of Medicine. Dietary Reference Values for Thiamin, Riboflavin, Niacin, Vitamin B6, Folate, Vitamin B12, Pantothenic Acid, Biotin and Choline. Washington, DC: National Academies Press; 1998.
3. Department of Health. Dietary Reference Values for Food Energy and Nutrients for the United Kingdom. London, UK: Her Majesty's Stationery Office; 1991.
4. Scientific Committee for Food. Nutrient and Energy Intakes for the European Community. Luxemburg: Commission of the European Communities; 1993.
5. Bates CJ, Pentieva KD, Prentice A. An appraisal of vitamin B6 status indices and associated confounders, in young people aged 4-18 years and in people aged 65 years and over, in two national British surveys. Public Health Nutr. 1999;2:529-535.
6. Bender DA. Lack of concordance between two indices of vitamin B6 nutritional status. Proc Nutr Soc. 1993;52:315a.
7. Bender DA. Nutritional Biochemistry of the Vitamins. 2nd ed. New York, NY: Cambridge University Press; 2003.
8. Palm D, Klein HW, Schinzel R, et al. The role of pyridoxal 5'-phosphate in glycogen phosphorylase catalysis. Biochemistry. 1990;29:1099-1107.
9. Bender DA. Oestrogens and vitamin B6: actions and interactions. World Rev Nutr Diet. 1987;51:140-188.
10. Frimpter GW, Andelman RJ, George WF. Vitamin B6-dependency syndromes: new horizons in nutrition. Am J Clin Nutr. 1969;22:794-805.
11. Mudd SH. Pyridoxine-responsive genetic disease. Fed Proc. 1971;30:970-976.
12. Clayton PT. B6-responsive disorders: a model of vitamin dependency. J Inherit Metab Dis. 2006;29:317-326.
13. Lheureux P, Penaloza A, Gris M. Pyridoxine in clinical toxicology: a review. Eur J Emerg Med. 2005;12:78-85.
14. Phillips WE, Mills JH, Charbonneau SM, et al. Subacute toxicity of pyridoxine hydrochloride in the beagle dog. Toxicol Appl Pharmacol. 1978;44:323-333.
15. Krinke G, Schaumburg HH, Spencer PS, et al. Pyridoxine megavitaminosis produces degeneration of peripheral sensory neurons (sensory neuropathy) in the dog. Neurotoxicology. 1980;2:13-24.
16. Schaeppi U, Krinke G. Pyridoxine neuropathy: correlation of functional tests and neuropathology in beagle dogs treated with large doses of vitamin B6. Agents Actions. 1982;12:575-582.
17. Schaumburg H, Kaplan J, Windebank A, et al. Sensory neuropathy from pyridoxine abuse: a new megavitamin syndrome. N Engl J Med. 1983;309:445-448.
18. Berger AR, Schaumburg HH, Schroeder C, et al. Dose response, coasting, and differential fiber vulnerability in human toxic neuropathy: a prospective study of pyridoxine neurotoxicity. Neurology. 1992;42:1367-1370.
19. McLachlan RS, Brown WF. Pyridoxine dependent epilepsy with iatrogenic sensory neuronopathy. Can J Neurol Sci. 1995;22:50-51.
20. Mpofu C, Alani SM, Whitehouse C, et al. No sensory neuropathy during pyridoxine treatment in homocystinuria. Arch Dis Child. 1991;66:1081-1082.
21. Brush MG, Bennett T, Hansen K. Pyridoxine in the treatment of premenstrual syndrome: a retrospective survey in 630 patients. Br J Clin Pract. 1988;42:448-452.
22. Dalton K, Dalton MJ. Characteristics of pyridoxine overdose neuropathy syndrome. Acta Neurol Scand. 1987;76:8-11.
23. Scientific Committee on Food. Opinion of the Scientific Committee on Food on the Tolerable Upper Intake Level of Vitamin B6. http://ec.europa.eu/food/fs/sc/scf/out80c_en.pdf. Accessed August 15, 2010.
24. Expert Group on Vitamins and Minerals. Safe upper levels for vitamins and minerals. http://www.foodstandards.gov.uk/science/ourad-visors/vitandmin. Accessed August 15, 2010.
25. Rose DP. Excretion of xanthurenic acid in the urine of women taking progesterone-oestrogen preparations. Nature. 1966;210: 196-197.
26. Rose DP. The influence of oestrogens on tryptophan metabolism in man. Clin Sci. 1966;31:265-272.
27. Bender DA, Wynick D. Inhibition of kynureninase (L-kynurenine hydrolase, EC 3.7.1.3) by oestrone sulphate: an alternative explanation for abnormal results of tryptophan load tests in women receiving oestrogenic steroids. Br J Nutr. 1981;45:269-275.
28. Meister A. On the transamination of enzymes. Ann N Y Acad Sci. 1990;585:13-31.
29. Allgood VE, Powell-Oliver FE, Cidlowski JA. The influence of vitamin B6 on the structure and function of the glucocorticoid receptor. Ann N Y Acad Sci. 1990;585:452-465.
30. Tully DB, Allgood VE, Cidlowski JA. Modulation of steroid receptor-mediated gene expression by vitamin B6. FASEB J. 1994;8:343-349.
31. Allgood VE, Cidlowski JA. Vitamin B6 modulates transcriptional activation by multiple members of the steroid hormone receptor superfamily. J Biol Chem. 1992;267:3819-3824.
32. Ritchie CD, Singkamani R. Plasma pyridoxal 5'-phosphate in women with the premenstrual syndrome. Hum Nutr Clin Nutr. 1986;40:75-80.
33. van den Berg H, Louwerse ES, Bruinse HW, et al. Vitamin B6 status of women suffering from premenstrual syndrome. Hum Nutr Clin Nutr. 1986;40:441-450.
34. Mira M, Stewart PM, Abraham SF. Vitamin and trace element status in premenstrual syndrome. Am J Clin Nutr. 1988;47:636-641.
35. Kleijnen J, Ter Riet G, Knipschild P. Vitamin B6 in the treatment of the premenstrual syndrome: a review. Br J Obstet Gynaecol. 1990;97:847-852.
36. Hagen I, Nesheim BI, Tuntland T. No effect of vitamin B-6 against premenstrual tension: a controlled clinical study. Acta Obstet Gynecol Scand. 1985;64:667-670.
37. Whelan AM, Jurgens TM, Naylor H. Herbs, vitamins and minerals in the treatment of premenstrual syndrome: a systematic review. Can J Clin Pharmacol. 2009;16:e407-e429.
38. Jewell D, Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev. 2003(4):CD000145.
39. Schuster K, Bailey LB, Dimperio D, et al. Morning sickness and vitamin B6 status of pregnant women. Hum Nutr Clin Nutr. 1985; 39:75-79.
40. Brent RL. Bendectin: review of the medical literature of a comprehensively studied human nonteratogen and the most prevalent tortogen-litigen. Reprod Toxicol. 1995;9:337-349.
41. Thaver D, Saeed MA, Bhutta ZA. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database Syst Rev. 2006; (2):CD000179.
42. Kutcher JS, Engle A, Firth J, et al. Bendectin and birth defects. II: Ecological analyses. Birth Defects Res A Clin Mol Teratol. 2003; 67:88-97.
43. Bender DA. Biochemistry of tryptophan in health and disease. Mol Aspects Med. 1983;6:101-197.
44. Dakshinamurti K, LeBlancq WD, Herchl R, et al. Nonparallel changes in brain monoamines of pyridoxine-deficient growing rats. Exp Brain Res. 1976;26:355-366.
45. Perry TL, Yong VW, Kish SJ, et al. Neurochemical abnormalities in brains of renal failure patients treated by repeated hemodialy-sis. J Neurochem. 1985;45:1043-1048.
46. Bender DA, Totoe L. High doses of vitamin B6 in the rat are associated with inhibition of hepatic tryptophan metabolism and increased uptake of tryptophan into the brain. J Neurochem. 1984;43:733-736.
47. Belongia EA, Mayeno AN, Osterholm MT. The eosinophilia-myalgia syndrome and tryptophan. Annu Rev Nutr. 1992;12: 235-256.
48. Varga J, Uitto J, Jimenez SA. The cause and pathogenesis of the eosinophilia-myalgia syndrome. Ann Intern Med. 1992;116: 140-147.
49. Wynn V, Doar JW. Some effects of oral contraceptives on carbohydrate metabolism. Lancet. 1966;(2):715-719.
50. Bennink HJ, Schreurs WH. Improvement of oral glucose tolerance in gestational diabetes by pyridoxine. Br Med J. 1975;3: 13-15.
51. Adams PW, Wynn V, Folkard J, et al. Influence of oral contraceptives, pyridoxine (vitamin B6) and tryptophan on carbohydrate metabolism. Lancet. 1976;(1):759-764.
52. Spellacy WN, Buhi WC, Birk SA. Vitamin B6 treatment of gesta-tional diabetes mellitus: studies of blood glucose and plasma insulin. Am J Obstet Gynecol. 1977;127:599-602.
53. Rose DP, Leklem JE, Brown RR, et al. Effect of oral contraceptives and vitamin B6 deficiency on carbohydrate metabolism. Am J Clin Nutr. 1975;28:872-878.
54. Bender DA, Totoe L. Inhibition of tryptophan metabolism by oes-trogens in the rat: a factor in the aetiology of pellagra. Br J Nutr. 1984;51:219-224.
55. van de Kamp JL, Smolen A. Response of kynurenine pathway enzymes to pregnancy and dietary level of vitamin B-6. Pharmacol Biochem Behav. 1995;51:753-758.
56. Kotake Y, Ueda T, Mori T, et al. The physiological significance of the xanthurenic acid-insulin complex. J Biochem (Tokyo). 1975;77:685-687.
57. Noto Y, Okamoto H. Inhibition by kynurenine metabolites of proinsulin synthesis in isolated pancreatic islets. Acta Diabetol Lat. 1978;15(5-6):273-282.
58. Rogers KS, Evangelista SJ. 3-Hydroxykynurenine, 3-hydroxy -anthranilic acid, and o-aminophenol inhibit leucine-stimulated insulin release from rat pancreatic islets. Proc Soc Exp Biol Med. 1985;178:275-278.
59. Solomon LR, Cohen K. Erythrocyte O2 transport and metabolism and effects of vitamin B6 therapy in type II diabetes mellitus. Diabetes. 1989;38:881-886.
60. Ganea E, Harding JJ. Lens proteins changes induced by sugars and pyridoxal phosphate. Ophthalmic Res. 1996;28(suppl 1): 65-68.
61. Voziyan PA, Hudson BG. Pyridoxamine: the many virtues of a Maillard reaction inhibitor. Ann N Y Acad Sci. 2005;1043:807-816.
62. Voziyan PA, Hudson BG. Pyridoxamine as a multifunctional pharmaceutical: targeting pathogenic glycation and oxidative damage. Cell Mol Life Sci. 2005;62:1671-1681.
63. Chang KC, Liang JT, Tsai PS, et al. Prevention of arterial stiffening by pyridoxamine in diabetes is associated with inhibition of the pathogenic glycation on aortic collagen. Br J Pharmacol. 2009;157:1419-1426.
64. Hagiwara S, Gohda T, Tanimoto M, et al. Effects of pyridoxamine (K-163) on glucose intolerance and obesity in high-fat diet C57BL/6J mice. Metabolism. 2009;58:934-945.
65. Murakoshi M, Tanimoto M, Gohda T, et al. Pleiotropic effect of pyridoxamine on diabetic complications via CD36 expression in KK-Ay/Ta mice. Diabetes Res Clin Pract. 2009;83:183-189.
66. Tanimoto M, Gohda T, Kaneko S, et al. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice. Metabolism. 2007; 56:160-167.
67. Padival S, Nagaraj RH. Pyridoxamine inhibits Maillard reactions in diabetic rat lenses. Ophthalmic Res. 2006;38:294-302.
68. Zheng F, Zeng YJ, Plati AR, et al. Combined AGE inhibition and ACEi decreases the progression of established diabetic nephropa-thy in B6 db/db mice. Kidney Int. 2006;70:507-514.
69. Williams ME, Bolton WK, Khalifah RG, et al. Effects of pyridox-amine in combined phase 2 studies of patients with type 1 and type 2 diabetes and overt nephropathy. Am J Nephrol. 2007;27: 605-614.
70. Verhoef P, Stamler MJ. Prospective studies of homocysteine and cardiovascular disease. Nutr Rev. 1995;53:283-288.
71. Boers GHJ. Hyperhomocysteinaemia as a risk factor for arterial and venous disease: a review of evidence and relevance. Thromb Haemost. 1997;78:520-522.
72. D'Angelo A, Selhub J. Homocysteine and thrombotic disease. Blood. 1997;90:1-11.
73. Linkswiler HM. Methionine metabolism as affected by vitamin B-6 deficiency. In: Leklem JE, Reynolds RD, eds. Methods in Vitamin B-6 Nutrition: Analysis and Status Assessment. New York, NY: Plenum Press; 1981:373-382.
74. Selhub J, Jacques PF, Wilson PW, et al. Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA. 1993;270:2693-2698.
75. Clarke R, Armitage J. Vitamin supplements and cardiovascular risk: review of the randomized trials of homocysteine-lowering vitamin supplements. Semin Thromb Hemost. 2000;26:341-348.
76. Marti-Carvajal AJ, Sola I, Lathyris D, et al. Homocysteine lowering interventions for preventing cardiovascular events. Cochrane Database Syst Rev. 2009;(4):CD006612.
77. Sanchez-Moreno C, Jimenez-Escrig A, Martin A. Stroke: roles of B vitamins, homocysteine and antioxidants. Nutr Res Rev. 2009; 22:49-67.
78. McNulty H, Pentieva K, Hoey L, et al. Homocysteine, B-vitamins and CVD. Proc Nutr Soc. 2008;67:232-237.
79. Spence JD. Homocysteine-lowering therapy: a role in stroke prevention? Lancet Neurol. 2007;6:830-838.
80. Perna AF, Ingrosso D, Violetti E, et al. Hyperhomocysteinemia in uremia: a red flag in a disrupted circuit. Semin Dial. 2009;22: 351-356.
81. Friedman AN. Pharmacologic B-vitamin therapy for hyperhomo-cysteinemia in dialysis patients: has the time come? Nutr Clin Care. 2002;5:20-24.
82. Dakshinamurti K, Lal KJ. Vitamins and hypertension. World Rev Nutr Diet. 1992;69:40-73.
83. Lal KJ, Dakshinamurti K. Calcium channels in vitamin B6 deficiency-induced hypertension. J Hypertens. 1993;11:1357-1362.
84. Dakshinamurti K, Dakshinamurti S. Blood pressure regulation and micronutrients. Nutr Res Rev. 2001;14:3-44.
85. Dakshinamurti K, Lal KJ, Ganguly PK. Hypertension, calcium channel and pyridoxine (vitamin B6). Mol Cell Biochem. 1998;188:137-148.
86. Vasdev S, Wadhawan S, Ford CA, et al. Dietary vitamin B6 supplementation prevents ethanol-induced hypertension in rats. Nutr Metab Cardiovasc Dis. 1999;9:55-63.
87. Vasdev S, Ford CA, Parai S, et al. Dietary vitamin B6 supplementation attenuates hypertension in spontaneously hypertensive rats. Mol Cell Biochem. 1999;200:155-162.
88. Lal KJ, Dakshinamurti K, Thliveris J. The effect of vitamin B6 on the systolic blood pressure of rats in various animal models of hypertension. J Hypertens. 1996;14:355-363.
89. Fregly MJ, Cade JR. Effect of pyridoxine and tryptophan, alone and combined, on the development of deoxycorticosterone acetate-induced hypertension in rats. Pharmacology. 1995;50:298-306.
90. Lin PT, Cheng CH, Wei JC, et al. Low plasma pyridoxal 5'-phosphate concentration and MTHFR 677C->T genotypes are associated with increased risk of hypertension. Int J Vitam Nutr Res. 2008;78:33-40.
91. Aybak M, Sermet A, Ayyildiz MO, et al. Effect of oral pyridoxine hydrochloride supplementation on arterial blood pressure in patients with essential hypertension. Arzneimittel-forschung. 1995;45:1271-1273.
92. Chan P, Huang TY, Chen YJ, et al. Randomized, double-blind, placebo-controlled study of the safety and efficacy of vitamin B complex in the treatment of nocturnal leg cramps in elderly patients with hypertension. J Clin Pharmacol. 1998;38:1151-1154.
93. Brophy MH, Siiteri PK. Pyridoxal phosphate and hypertensive disorders of pregnancy. Am J Obstet Gynecol. 1975;121:1075-1079.
94. Riggs KM, Spiro A III, Tucker K, et al. Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr. 1996;63:306-314.
95. Spinneker A, Sola R, Lemmen V, et al. Vitamin B6 status, deficiency and its consequences: an overview. Nutr Hosp. 2007;22:7-24.
96. Deijen JB, van der Beek EJ, Orlebeke JF, et al. Vitamin B-6 supplementation in elderly men: effects on mood, memory, performance and mental effort. Psychopharmacology (Berl). 1992;109:489-496.
97. Molimard R, Marillaud A, Paille A, et al. Impairment of memorization by high doses of pyridoxine in man. Biomedicine. 1980;32:88-92.
98. Balk E, Chung M, Raman G, et al. B vitamins and berries and age-related neurodegenerative disorders. Evid Rep Technol Assess (Full Rep). 2006;(134):1-161.
99. Balk EM, Raman G, Tatsioni A, et al. Vitamin B6, B12, and folic acid supplementation and cognitive function: a systematic review of randomized trials. Arch Intern Med. 2007;167:21-30.
100. Malouf R, Grimley Evans J. The effect of vitamin B6 on cognition. Cochrane Database Syst Rev. 2003;(4):CD004393.
101. Morris MC, Schneider JA, Tangney CC. Thoughts on B-vitamins and dementia. J Alzheimers Dis. 2006;9:429-433.
102. Nye C, Brice A. Combined vitamin B6-magnesium treatment in autism spectrum disorder. Cochrane Database Syst Rev. 2005; (4):CD003497.
103. Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009; 21:213-236.
104. Potera C, Rose DP, Brown RR. Vitamin B6 deficiency in cancer patients. Am J Clin Nutr. 1977;30:1677-1679.
105. Bell E. The excretion of a vitamin B6 metabolite and the probability of recurrence of early breast cancer. Eur J Cancer. 1980;16:297-298.
106. Key TJ, Silcocks PB, Davey GK, et al. A case-control study of diet and prostate cancer. Br J Cancer. 1997;76:678-687.
107. Larsson SC, Orsini N, Wolk A. Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA. 2010;303: 1077-1083.
108. Komatsu SI, Watanabe H, Oka T, et al. Vitamin B-6-supplemented diets compared with a low vitamin B-6 diet suppress azoxymethane-induced colon tumorigenesis in mice by reducing cell proliferation. J Nutr. 2001;131:2204-2207.
109. Komatsu S, Yanaka N, Matsubara K, et al. Antitumor effect of vitamin B6 and its mechanisms. Biochim Biophys Acta. 2003; 1647:127-130.
110. Matsubara K, Komatsu S, Oka T, et al. Vitamin B6-mediated suppression of colon tumorigenesis, cell proliferation, and angiogenesis (review). J Nutr Biochem. 2003;14:246-250.
111. Ebbing M, Bonaa KH, Nygard O, et al. Cancer incidence and mortality after treatment with folic acid and vitamin B12. JAMA. 2009;302:2119-2126.
112. Ellis JM, Kishi T, Azuma J, et al. Vitamin B6 deficiency in patients with a clinical syndrome including the carpal tunnel defect: biochemical and clinical response to therapy with pyridoxine. Res Commun Chem Pathol Pharmacol. 1976;13:743-757.
113. Ellis JM, Azuma J, Watanabe T, et al. Survey and new data on treatment with pyridoxine of patients having a clinical syndrome including the carpal tunnel and other defects. Res Commun Chem Pathol Pharmacol. 1977;17:165-177.
114. Folkers K, Ellis J, Watanabe T, et al. Biochemical evidence for a deficiency of vitamin B6 in the carpal tunnel syndrome based on a crossover clinical study. Proc Natl Acad Sci USA. 1978;75: 3410-3412.
115. Ellis J, Folkers K, Watanabe T, et al. Clinical results of a crossover treatment with pyridoxine and placebo of the carpal tunnel syndrome. Am J Clin Nutr. 1979;32:2040-2046.
116. Ellis J, Folkers K, Levy M, et al. Therapy with vitamin B6 with and without surgery for treatment of patients having the idio-pathic carpal tunnel syndrome. Res Commun Chem Pathol Pharmacol. 1981;33:331-344.
117. Ellis JM. Treatment of carpal tunnel syndrome with vitamin B6. South Med J. 1987;80:882-884.
118. Aufiero E, Stitik TP, Foye PM, et al. Pyridoxine hydrochloride treatment of carpal tunnel syndrome: a review. Nutr Rev. 2004;62:96-104.
119. O'Connor D, Marshall S, Massy-Westropp N. Non-surgical treatment (other than steroid injection) for carpal tunnel syndrome. Cochrane Database Syst Rev. 2003;(1): CD003219.
120. Piazzini DB, Aprile I, Ferrara PE, et al. A systematic review of conservative treatment of carpal tunnel syndrome. Clin Rehabil. 2007;21:299-314.